| 1 |
NOC's for manufacture of Unapproved/Banned/New Drugs Solely for Export Purpose |
2024-Apr-30 |
|
454 KB |
| 2 |
Stakeholder consultation for feedback on SEC meetings dated 22.04.2024 |
2024-Apr-22 |
|
272 KB |
| 3 |
Manufacturing and marketing of unapproved drug Meropenam 1gm + EDTA for Injection |
2024-Apr-16 |
|
366 KB |
| 4 |
Public Notice regarding DCGI meeting with Stakeholders Dated 15.04.2024 for 18 April 2024 Meeting cancellation |
2024-Apr-15 |
|
143 KB |
| 5 |
Public Notice regarding Draft CDSCO Guidance for Industry Version 1.2 |
2024-Apr-10 |
|
1184 KB |
| 6 |
Public Notice regarding DCGI meeting with Stakeholders Dated 08.04.2024 for 16 April 2024 Meeting cancellation |
2024-Apr-08 |
|
142 KB |
| 7 |
Implementation and effective use of RTI-MIS Portal (e-Portal) for disposal of all RTI including Physical RTI through RTI-MIS across all the CDSCO offices as per DoPT Order dated 12th August 2013 under RTI Act 2005 |
2024-Apr-05 |
|
111 KB |
| 8 |
Notice to All stakeholders for Strengthening of Private Medical Device Testing Laboratory |
2024-Apr-03 |
|
388 KB |
| 9 |
Public Notice regarding DCGI meeting with Stakeholders Dated 26.03.2024 for 28 march 2024 Meeting cancellation |
2024-Mar-26 |
|
142 KB |
| 10 |
Meeting through WebEx Video-conference of the DTAB-sub Committee on 05.04.2024 at 11.00 a.m. to 6:00 p.m. to Evaluation of 16 FDCs which were earlier considered as irrational in the Expert Committee report of the Prof. Kokate Committee |
2024-Mar-22 |
|
409 KB |
